Advised a client on the licensing of a joint development project between a U.S. pharmaceutical company and a Chinese pharmaceutical company.

Represented more than a dozen foreign clients in joint ventures or strategic alliances in China and other jurisdictions (including Hong Kong, Singapore, the Cayman Islands, the British Virgin Islands, and the United States), including Regal Beloite and East Pennsylvania Manufacturing.

Represented and participated in multiple transactions involving U.S. investors in the sale of their interests in Chinese entities.

Shanghai Automotive Air Conditioning Factory (SAACF) in its acquisition of the equity interest in the joint venture between Dephi Automotive and SAACF.

Represented a large U.S. high-tech company in its strategic acquisitions of multiple companies or assets, involving deep learning, cloud technology, CDMA business, etc.

Represented Google Capital in its proposed acquisition of a Chinese online education website.

Represented Hepalink, a Shenzhen Stock Exchange listed company, in its acquisition of its U.S. competitor and investment in a U.S. healthcare fund.

Represented Industrial and Commercial Bank of China in its acquisition of a Taiwanese commercial bank.

Acted for the owner of a Chinese hospital in the restructuring and sale of its business to a UK strategic investor.

Represented a Chinese healthcare fund in its pre-IPO investments in various U.S. companies.

Represented a well-known U.S. pharmaceutical company in its investment in a Chinese pharmaceutical company through its Asian fund. Represented Chinese investors in the Series F investment in AirBnB and Uber.

Represented several startups in multiple rounds of financing.